Merck KGaA (Germany) Today
| MRK Stock | 141.85 0.25 0.18% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Merck KGaA is selling for under 141.85 as of the 3rd of December 2024; that is 0.18% up since the beginning of the trading day. The stock's last reported lowest price was 140.35. Merck KGaA has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Merck KGaA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of November 2024 and ending today, the 3rd of December 2024. Click here to learn more.
Moving against Merck Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Merck Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Merck KGaA's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Merck KGaA or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers-Specialty & Generic, Healthcare (View all Sectors) |
Merck KGaA (MRK) is traded on XETRA Stock Exchange in Germany and employs 63,723 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 76.08 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Merck KGaA's market, we take the total number of its shares issued and multiply it by Merck KGaA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Merck KGaA operates under Healthcare sector and is part of Drug Manufacturers-Specialty & Generic industry. The entity has 129.24 M outstanding shares.
Merck KGaA generates positive cash flow from operations, but has no cash available
Check Merck KGaA Probability Of Bankruptcy
Ownership AllocationMerck KGaA maintains a total of 129.24 Million outstanding shares. Over half of Merck KGaA's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Merck KGaA. Please watch out for any change in the institutional holdings of Merck KGaA as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Merck Ownership Details
Merck KGaA Risk Profiles
Although Merck KGaA's alpha and beta are two of the key measurements used to evaluate Merck KGaA's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.07 | |||
| Standard Deviation | 1.64 | |||
| Variance | 2.67 | |||
| Risk Adjusted Performance | (0.14) |
Merck Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Merck KGaA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio File Import Now
Portfolio File ImportQuickly import all of your third-party portfolios from your local drive in csv format |
| All Next | Launch Module |
Merck KGaA Corporate Management
Elected by the shareholders, the Merck KGaA's board of directors comprises two types of representatives: Merck KGaA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Merck. The board's role is to monitor Merck KGaA's management team and ensure that shareholders' interests are well served. Merck KGaA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Merck KGaA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Peter Guenter | CEO Board | Profile | |
| Matthias Heinzel | CEO Board | Profile | |
| Dirk Toepfer | Chief Officer | Profile | |
| Barbara Weiland | Chief Officer | Profile | |
| Gerhard Schmitz | Head Accounting | Profile | |
| Belen MD | Chair CEO | Profile | |
| Kai Beckmann | CEO Board | Profile |
Additional Tools for Merck Stock Analysis
When running Merck KGaA's price analysis, check to measure Merck KGaA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck KGaA is operating at the current time. Most of Merck KGaA's value examination focuses on studying past and present price action to predict the probability of Merck KGaA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck KGaA's price. Additionally, you may evaluate how the addition of Merck KGaA to your portfolios can decrease your overall portfolio volatility.